News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Skvarka Jan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Skvarka Jan (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 16,364 shares
@ $0 |
|
| 03/31/2023 |
4
| Skvarka Jan (Director) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 41,000 options to buy
@ $7.36, valued at
$301.8k
|
|
| 03/24/2023 |
3
| Skvarka Jan (Director) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
| 09/12/2022 |
4
| Skvarka Jan (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 36,606 shares
@ $0 |
|
| 09/12/2022 |
3
| Skvarka Jan (Director) has filed a Form 3 on Zentalis Pharmaceuticals, Inc. |
| 11/19/2021 |
4
| Skvarka Jan (President and CEO) has filed a Form 4 on Trillium Therapeutics Inc.|
Txns:
| Disposed/sold 197,000 options to buy
@ $0
Disposed/sold 1,162,500 options to buy
@ $0
Disposed/sold 600,000 options to buy
@ $12.03, valued at
$7.2M
|
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|